Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: author exact 801001803550 cql: author exact 801000461213 Add to list Journal Article A1 Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist Nutlin-3 Tom Van Maerken (UGent) , Ali Rihani (UGent) , Daniel Dreidax, Sarah De Clercq (UGent) , Nurten Yigit (UGent) , Jean-Christophe Marine (UGent) , Frank Westermann, Anne De Paepe (UGent) , Jo Vandesompele (UGent) and Franki Speleman (UGent) (2011) MOLECULAR CANCER THERAPEUTICS. 10(6). p.983-993 Add to list Journal Article A1 Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53 Tom Van Maerken (UGent) , Liesbeth Ferdinande (UGent) , Jasmien Taildeman (UGent) , Irina Lambertz (UGent) , Nurten Yigit (UGent) , Liesbeth Vercruysse (UGent) , Ali Rihani (UGent) , Martin Michaelis, Jindrich Cinatl, Claude Cuvelier (UGent) , et al. (2009) JOURNAL OF THE NATIONAL CANCER INSTITUTE. 101(22). p.1562-1574 Add to list Journal Article A2 open access Real-time qPCR as a tool for evaluating RNAi-mediated gene silencing Tom Van Maerken (UGent) , Pieter Mestdagh (UGent) , Sarah De Clercq (UGent) , Filip Pattyn (UGent) , Nurten Yigit (UGent) , Anne De Paepe (UGent) , Jean-Christophe Marine (UGent) , Franki Speleman (UGent) and Jo Vandesompele (UGent) (2008) Bioradiations. 124. p.16-21 Add to list Journal Article A1 Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma Tom Van Maerken (UGent) , Franki Speleman (UGent) , J VERMEULEN, Irina Lambertz (UGent) , Sarah De Clercq (UGent) , Els De Smet (UGent) , Nurten Yigit (UGent) , V COPPENS, Jan Philippé (UGent) , Anne De Paepe (UGent) , et al. (2006) CANCER RESEARCH. 66(19). p.9646-9655